Shares of Koninklijke Philips (NYSE:PHG – Get Free Report) have been given a consensus rating of “Hold” by the five analysts that are covering the company, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company.
Several equities research analysts have issued reports on PHG shares. Jefferies Financial Group raised Koninklijke Philips from an “underperform” rating to a “hold” rating in a report on Tuesday, October 29th. StockNews.com cut shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Thursday, November 14th.
Read Our Latest Stock Report on PHG
Koninklijke Philips Price Performance
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the company. FMR LLC increased its stake in shares of Koninklijke Philips by 0.6% in the 3rd quarter. FMR LLC now owns 6,138,708 shares of the technology company’s stock valued at $200,859,000 after purchasing an additional 35,935 shares during the last quarter. Creative Planning boosted its stake in Koninklijke Philips by 39.3% in the third quarter. Creative Planning now owns 84,263 shares of the technology company’s stock valued at $2,757,000 after buying an additional 23,768 shares in the last quarter. Envestnet Portfolio Solutions Inc. grew its position in Koninklijke Philips by 12.9% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 26,515 shares of the technology company’s stock valued at $668,000 after acquiring an additional 3,040 shares during the last quarter. International Assets Investment Management LLC acquired a new position in Koninklijke Philips during the third quarter worth about $1,360,000. Finally, Sanctuary Advisors LLC acquired a new position in Koninklijke Philips during the second quarter worth about $1,253,000. 13.67% of the stock is currently owned by institutional investors and hedge funds.
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories
- Five stocks we like better than Koninklijke Philips
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- What Are Some of the Best Large-Cap Stocks to Buy?
- CarMax Gets in Gear: Is Now the Time to Buy?
- What is the Euro STOXX 50 Index?
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.